Ipsophène plans to produce 4,000 tonnes of paracetamol per year, or 40% of French production and 7% of European consumption. All raw materials will be of French or European origin.
The company plans to hire between 35 and 40 permanent employees by the end of the year. “Our cost price will also allow us to remain competitive. More fundamentally, we will always have the capacity to produce paracet amol even if there is any disruption in the supply chain from Asia,” assures Jean Boher.